CompoAtlas

DR. RECKEWEG Rekin 71

Natural health product licensed in Canada

Licence holder
Bio Lonreco Inc.
NPN or DIN-HM
80053002
Status
Active licence
Licence date
11 August 2014
Revision date
Not provided
Form
Liquid (drinkable ampoules)
Route of administration
Orale
Application type
Homéopathique

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Magnesium phosphoricum

Source : Hydrogénophosphate de magnesium trihydrate

8 DNot calculated
Aconitum

Source : Plante entière fraîche récoltée au début de la floraison

4 DNot calculated
Arsenicum album

Source : Trioxyde arsénieux

30 DNot calculated
Colocynthis

Source : Fruits dégrainés, pelés, et séchés ou morceaux de ceux-ci

4 DNot calculated
Gnaphalium polycephalum

Source : Plante entière

3 DNot calculated

Non-medicinal ingredients

Chlorure de sodium

PopulationAgeQuantity per servingFrequency
Adultes et enfantsminimum: 12 years1 ampoule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Homeopathic Medicine

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80053002

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line